These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression. Kyle RA, Rajkumar SV. Br J Haematol; 2007 Dec; 139(5):730-43. PubMed ID: 18021088 [Abstract] [Full Text] [Related]
5. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients. Zhang CY, Lu LJ, Li FH, Li HL, Gu YY, Chen SL, Bao CD. J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290 [Abstract] [Full Text] [Related]
13. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study. Mok CC, Ho LY, Cheung MY, Yu KL, To CH. Scand J Rheumatol; 2009 Feb; 38(2):121-7. PubMed ID: 18991189 [Abstract] [Full Text] [Related]
14. Monoclonal gammopathy in a tertiary referral hospital. Tamimi W, Alaskar A, Alassiri M, Alsaeed W, Alarifi SA, Alenzi FQ, Jawdat D. Clin Biochem; 2010 Jun; 43(9):709-13. PubMed ID: 20206156 [Abstract] [Full Text] [Related]